KATHERINE MAHDAVI: Open Payments
NPI 1972379758 · ANNAPOLIS, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,062 in 76 payments from 21 companies in 2025. Trend: 2023 $0 · 2024 $1,399 · 2025 $2,062
Food & beverage: $1,882Education: $180
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 11 | $407 |
| GENZYME CORPORATION | 10 | $327 |
| ABBVIE INC. | 14 | $288 |
| Novartis Pharmaceuticals Corporation | 8 | $168 |
| Amgen Inc. | 5 | $98 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $97 |
| SANOFI-AVENTIS U.S. LLC | 1 | $97 |
| Incyte Corporation | 4 | $94 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $65 |
| Organogenesis Inc. | 1 | $60 |
Products named: DUPIXENT, TREMFYA, SKYRIZI, COSENTYX, OTEZLA, SPEVIGO, OPZELURA, ILUMYA.
Industry payments across MD — which companies pay providers there.
